查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2018065

腎臟病治療設備市場：按產品類型、治療方式和最終用戶分類 - 2026-2032年全球市場預測

Nephrology Devices Market by Product Type, Modality, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，用於治療腎臟疾病的醫療設備市場價值將達到 179.3 億美元，到 2026 年將成長到 193.1 億美元，到 2032 年將達到 310.4 億美元，複合年成長率為 8.14%。

主要市場統計數據
基準年 2025 179.3億美元
預計年份：2026年 193.1億美元
預測年份 2032 310.4億美元
複合年成長率 (%) 8.14%

本書權威地概述了腎臟疾病治療設備領域，重點關注臨床緊迫性、技術進步、不斷發展的護理模式和不斷變化的採購重點。

全球腎臟疾病治療設備市場正處於臨床緊迫性、技術創新和不斷演變的醫療服務模式的交匯點。慢性腎臟病盛行率的不斷上升、人口老化以及對保護殘餘腎功能的日益重視，持續推動著對安全、高效且以患者為中心的治療方法的臨床需求。同時，感測器技術、數位療法和新型薄膜材料的進步，催生了新一代醫療設備，這些設備優先考慮便攜性、易用性和即時數據整合。這些因素共同重塑了採購重點和臨床路徑，迫使醫療服務提供者和保險公司重新評估資本配置和服務提供模式。

本文探討了正在重新定義用於治療腎臟疾病的醫療設備的變革性變化，包括家庭透析的廣泛應用、人工智慧驅動的護理、基於價值的獎勵以及供應鏈的現代化。

過去幾年，腎臟病治療設備領域發生了翻天覆地的變化，遠非簡單的產品改進所能比擬。家庭透析已從小眾選擇發展成為醫療機構的戰略重點，旨在降低系統成本並提高患者的生活品質，從而推動了針對非臨床環境最佳化的新產品設計。數位醫療和人工智慧診斷技術已從先導計畫走向全面部署，實現了更主動的液體管理、血管通路監測和個人化治療。因此，軟體、連結性和使用者體驗如今已成為醫療設備設計週期中的核心需求，而非附加功能。

評估美國關稅變更於 2025 年生效對採購、製造、購買和供應鏈韌性的累積營運和策略影響。

近期美國關稅趨勢及2025年前的政策調整對醫療設備醫療設備系統正在審查競標流程，以應對進口可能帶來的成本波動，這導致採購週期延長，並更加重視價格調整條款等合約保障措施。

透過對產品類型、模式和最終用戶環境的全面細分洞察，明確了臨床效用、監管途徑和商業化重點。

對整個腎臟醫療設備市場進行細緻的觀點對於確定產品開發和商業化優先事項至關重要。按產品類型分析，市場種類繁多，涵蓋配件、導管、連續性腎臟替代療法 (CRRT) 設備、透析器、血液透析機和腹膜透析系統。配件包括血液迴路組件、透析液濃縮液、過濾器和薄膜。導管包括腹膜透析導管和血管通路導管。連續性腎臟替代療法設備進一步細分為連續性靜脈-靜脈血液透析濾過、連續性靜脈-靜脈血液透析和連續性靜脈-靜脈血液濾過設備。透析器根據其高通量、低通量和超低通量結構而有所不同。血液透析機包括家用血液透析機、攜帶式血液透析機和固定式血液透析機。腹膜透析系統分為自動化腹膜透析系統及連續移動式腹膜透析系統。這些產品層面的差異導致了不同的監管途徑、報銷考慮和使用者培訓要求，從而影響部署時間表和投資重點。

詳細的區域分析表明，美洲、歐洲、中東和非洲以及亞太地區的趨勢正在影響用於治療腎臟疾病的醫療設備的監管、商業和部署策略。

區域趨勢對整個腎臟病治療設備生態系統的採用模式、監管預期和競爭地位有顯著影響。在美洲，醫療機構透析基礎設施長期完善，同時，受醫療機構整合、保險公司壓力和病患偏好變化等因素驅動，居家照護和綜合照護路徑的需求日益成長。這種環境有利於那些能夠簡化居家使用、減輕訓練負擔並與遠端監測平台整合的設備。相較之下，歐洲、中東和非洲地區的管理體制和報銷框架則呈現多樣化的特徵。雖然西歐市場通常優先考慮臨床證據和生命週期管理，但該地區的其他部分則需要靈活的商業模式和有針對性的宣傳活動來加速產品普及。這些差異使得每個子區域都需要製定差異化的打入市場策略和監管策略。

這提供了企業層面的策略洞察，揭示了成熟企業、專業供應商和創新新參與企業如何透過夥伴關係、材料和服務模式重塑競爭格局。

腎臟病治療設備領域的競爭動態由成熟製造商、專業組件供應商以及專注於數位化整合和便攜性的創新新參與企業共同塑造。成熟的透析設備製造商透過廣泛的服務網路、檢驗的生產流程以及支撐設備安全性的長期臨床數據，鞏固了其在臨床上的信譽。同時，專業的透析器和膜製造商正致力於推進材料科學，以改善其清除特性和生物相容性，這為系統供應商提供了透過耗材性能實現差異化競爭的機會。而新興參與企業，通常獲得創業投資和策略聯盟的支持，則大力推廣以使用者為中心的設計、遠端監控功能和簡化的維護系統，對老牌製造商在家庭和門診市場的地位構成了威脅。

為產業領導者提供切實可行的建議，以增強韌性、加速數位轉型、最佳化採購並有效擴大家用設備的普及應用。

產業領導者必須採取務實的策略，在不斷發展的腎臟病治療設備領域，平衡短期韌性與長期創新，才能取得成功。首先，優先採用模組化產品架構，將加快多種變體產品的監管申報速度，並縮短適應區域配置所需的時間，從而能夠快速應對關稅帶來的採購變化。其次，投資於可互通的數位平台，實現遠端監測、預測性維護以及與電子健康記錄的整合，將使產品脫穎而出，並促進與支付方和醫療服務提供者就基於價值的醫療服務展開討論。第三，應尋求策略供應商多元化和發展本地組裝能力，以降低進口風險，同時確保產品品質和合規性。所有這些努力都必須輔以嚴格的變更控制和臨床檢驗計劃。

本報告詳細介紹了所採用的透明混合方法研究方法，包括主要專家訪談、二手證據整合、檢驗方案和分析框架。

本分析所依據的研究採用了一種混合方法，將對具有專業知識的專家進行的結構化一手訪談與嚴謹的二手證據相結合。一手資料包括對臨床負責人、採購負責人、醫療設備工程師和監管專家的詳細訪談，以獲取關於推廣障礙、臨床優先排序和籌資策略的第一手觀點。這些見解與同儕審查的臨床文獻、公開的監管文件、專利申請和公司資訊披露等二級資訊來源進行交叉比對，以檢驗技術聲明和以往的產品趨勢。此外，還與各領域專家舉行了交叉檢驗研討會，以協調不同的觀點並完善每個主題的結論。

最終綜合分析將臨床趨勢、技術可行性、政策阻力和策略挑戰連結起來，這些因素將塑造腎臟病醫療設備的未來發展軌跡。

總之，腎臟病治療設備市場正進入一個以醫療保健日益分散化、對數位化整合的期望不斷提高以及對供應鏈和政策衝擊的敏感性增強為特徵的階段。臨床上對更安全、更以患者為中心的護理的需求，加上技術進步，為家庭和門診解決方案創造了前景廣闊的途徑，而精準性和可靠性在重症監護領域仍然至關重要。同時，價格趨勢和區域監管差異要求企業制定靈活的生產和商業化策略，以平衡全球規模和區域適應性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：腎臟病治療設備市場：依產品類型分類

  • 配件
    • 血液迴路裝置
    • 透析濃縮液
    • 過濾器和薄膜
  • 導管
    • 腹膜透析導管
    • 血管通路導管
  • 連續性腎臟替代治療裝置
  • 透析器
    • 高通量透析器
    • 低通量透析器
    • 超低通量透析器
  • 血液透析機
    • 家用血液透析機
    • 攜帶式血液透析機
    • 固定式血液透析機
  • 腹膜透析系統

第9章：腎臟疾病治療設備市場：依治療方式分類

  • 連續性腎臟替代療法
    • 連續性靜脈血液透析過濾
    • 持續性靜脈血液透析
    • 連續性靜脈血液濾過
  • 血液透析
    • 居家血液透析
    • 院內血液透析
  • 腹膜透析
    • 自動化腹膜透析
    • 持續性移動腹膜透析

第10章：腎臟病治療設備市場：依最終用戶分類

  • 門診手術中心
  • 居家照護設施
  • 醫院
  • 獨立透析中心

第11章：腎臟疾病治療設備市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第12章：腎臟疾病治療設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章：腎臟病治療設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章：美國腎臟病治療設備市場

第15章：中國腎臟病治療設備市場

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Allmed Medical Products Co., Ltd.
  • Asahi Kasei Corporation
  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • DaVita Inc.
  • Dialife SA
  • Diaverum AB
  • Fresenius Medical Care AG & Co. KGaA
  • Guangdong Biolight Meditech Co., Ltd.
  • Hemoclean Co., Ltd.
  • Isopure Corporation
  • JMS Co., Ltd.
  • Kawasumi Laboratories, Inc.
  • Lepu Medical Technology（Beijing）Co., Ltd.
  • Medtronic plc
  • Nikkiso Co., Ltd.
  • Nipro Corporation
  • Outset Medical, Inc.
  • Quanta Dialysis Technologies Ltd.
  • Rockwell Medical, Inc.
  • STERIS plc
  • Teleflex Incorporated
  • Toray Industries, Inc.
Product Code: MRR-030226489D4A

The Nephrology Devices Market was valued at USD 17.93 billion in 2025 and is projected to grow to USD 19.31 billion in 2026, with a CAGR of 8.14%, reaching USD 31.04 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 17.93 billion
Estimated Year [2026] USD 19.31 billion
Forecast Year [2032] USD 31.04 billion
CAGR (%) 8.14%

Authoritative introduction framing the nephrology devices sector amid clinical urgency, technological advances, evolving care models and shifting procurement priorities

The global nephrology devices arena sits at the intersection of clinical urgency, technological innovation, and shifting care delivery models. Chronic kidney disease prevalence, aging populations, and heightened emphasis on preserving residual renal function continue to drive clinical demand for safe, efficient and patient-centric therapies. At the same time, advances in sensor technologies, digital therapeutics, and novel membrane materials are enabling a new generation of devices that emphasize portability, ease of use and real-time data integration. These combined pressures are reshaping procurement priorities and clinical pathways, prompting providers and payers to reassess capital allocation and service delivery models.

Consequently, industry stakeholders must reconcile the tension between high-acuity inpatient therapies and expanding home-based alternatives. Regulatory frameworks are evolving to balance patient safety with expedited pathways for devices that demonstrably improve outcomes or reduce care burden. Meanwhile, supply chain resilience and component sourcing have gained prominence, with manufacturers increasingly investing in diversified supplier networks and nearshoring strategies. In sum, introduction to this landscape underscores a complex but opportunistic environment in which clinical needs, technological capability and system-level incentives converge to define the next wave of product development and commercial strategy.

Exploring the transformative shifts that are redefining nephrology devices including the rise of home dialysis, AI-enabled care, value-based incentives and supply chain modernization

Over the past several years the nephrology devices landscape has undergone transformative shifts that extend beyond incremental product improvements. Home dialysis adoption is evolving from a niche alternative to a strategic focus for providers seeking to lower system costs and enhance patient quality of life, and this movement is catalyzing new product designs optimized for non-clinical settings. Digital health and AI-enabled diagnostics are moving from pilot projects to operational deployments, enabling more proactive fluid management, vascular access monitoring and therapy personalization. As a result, device design cycles now integrate software, connectivity and user experience as core requirements rather than adjunct features.

At the same time, reimbursement and regulatory environments are encouraging value-based approaches that reward outcomes and patient experience, prompting manufacturers to demonstrate longitudinal clinical benefit and total-cost-of-care impact. Supply chain events and trade policy shifts have accelerated investments in manufacturing flexibility and supplier diversification. New entrants and cross-sector partnerships are increasing competitive intensity, with medical device firms collaborating with software vendors, diagnostics companies and care providers to deliver integrated solutions. These combined shifts are changing the calculus for R&D prioritization, go-to-market models and longer-term strategic alliances within the nephrology sector.

Assessing the cumulative operational and strategic impact of United States tariff changes effective in 2025 on sourcing, manufacturing, procurement and supply chain resilience

Recent tariff developments and policy adjustments in the United States for 2025 have generated a complex set of implications across device procurement, component sourcing and manufacturing strategies. For device makers that depend on globally sourced polymers, specialized membranes and precision components, tariff-related cost pressure has amplified the need to reassess supplier footprints and consider regional manufacturing or alternative materials where clinically appropriate. In parallel, purchasing organizations and hospital systems are re-evaluating tendering practices to incorporate potential import-related cost volatility, leading to longer procurement cycles and increased emphasis on contractual protections such as price adjustment clauses.

Moreover, tariffs have stimulated strategic responses that go beyond immediate price mitigation. Manufacturers are accelerating localization efforts, including partnerships with regional contract manufacturers and targeted investments in assembly operations closer to end markets. These moves are informed by a desire to preserve margin, protect supply continuity and reduce lead times. Importantly, regulatory requirements for device components and manufacturing process validation mean that any shift in sourcing or assembly requires careful clinical and quality planning to avoid downstream disruption. Thus, while tariffs pose cost and operational stress, they are also a catalyst for redesigning resilient supply chains and for rethinking value propositions in procurement discussions.

Comprehensive segmentation insights across product types, modalities and end-user settings that clarify clinical utility, regulatory paths and commercialization priorities

A granular segmentation perspective is critical to navigate product development and commercialization priorities across the nephrology devices spectrum. When dissected by product type, the market encompasses a spectrum ranging from accessories, catheters, continuous renal replacement therapy devices, dialyzers, hemodialysis machines, to peritoneal dialysis systems; accessories include blood tubing sets, dialysate concentrates and filters and membranes; catheters comprise peritoneal dialysis catheters and vascular access catheters; continuous renal replacement therapy devices are further differentiated into continuous venovenous hemodiafiltration, continuous venovenous hemodialysis and continuous venovenous hemofiltration devices; dialyzers vary across high flux, low flux and ultra low flux constructions; hemodialysis machines cover home hemodialysis machines, portable hemodialysis devices and stationary hemodialysis machines; peritoneal dialysis systems are segmented into automated and continuous ambulatory peritoneal dialysis systems. These product-level distinctions drive divergent regulatory pathways, reimbursement considerations and user training requirements that influence time-to-adoption and investment priorities.

Viewed through the modality lens, distinctions among continuous renal replacement therapy, hemodialysis and peritoneal dialysis reveal different clinical niches and adoption drivers; continuous renal replacement therapy subdivisions of continuous venovenous hemodiafiltration, continuous venovenous hemodialysis and continuous venovenous hemofiltration reflect intensive care applications where precision fluid and solute control are paramount, while hemodialysis differentiation between home and in-center use highlights trade-offs between device complexity and user ergonomics, and peritoneal dialysis bifurcation into automated and continuous ambulatory systems underscores patient lifestyle integration considerations. Finally, end-user segmentation across ambulatory surgical centers, home care settings, hospitals and standalone dialysis centers emphasizes that procurement cycles, service models and clinical staffing vary considerably by setting, shaping aftermarket service strategies and training investments. Taken together, segmentation clarity informs product roadmaps, commercial targeting and regulatory dossier planning.

In-depth regional insights showing how Americas, Europe Middle East & Africa, and Asia-Pacific dynamics shape regulatory, commercial and adoption strategies in nephrology devices

Regional dynamics materially influence adoption patterns, regulatory expectations and competitive positioning across the nephrology devices ecosystem. In the Americas, longstanding infrastructure for in-center dialysis coexists with a growing appetite for home therapies and integrated care pathways, driven by provider consolidation, payer pressure and patient preference shifts. This environment favors devices that simplify home use, reduce training burdens and integrate with remote monitoring platforms. In contrast, Europe, Middle East & Africa demonstrates heterogeneous regulatory regimes and reimbursement frameworks; Western European markets often prioritize clinical evidence and lifecycle management while other parts of the region require flexible commercial models and targeted education efforts to accelerate adoption. These disparities necessitate differentiated go-to-market and regulatory strategies across subregions.

Meanwhile, Asia-Pacific markets present a mix of high-volume opportunities and price sensitivity, alongside rapid uptake of portable and automated solutions in urban centers where home care infrastructure is progressing. Local manufacturing capabilities and regional standards can accelerate deployment when companies align product configurations and pricing with local needs. Across all regions, interoperability, clinical training, and after-sales service are decisive factors that determine market penetration and long-term device utilization. Therefore, regional strategies must reconcile global platform efficiencies with local adaptation to regulatory, economic and care delivery realities.

Strategic company-level insights describing how incumbents, specialized suppliers and innovative entrants are reshaping competition through partnerships, materials and service models

Competitive dynamics in nephrology devices are defined by a mix of legacy manufacturers, specialized component producers and innovative newcomers focused on digital integration and portability. Established dialysis equipment manufacturers continue to anchor clinical trust through extensive service networks, validated manufacturing processes and long-term clinical data supporting device safety. At the same time, specialized dialyzer and membrane producers are advancing material science to improve clearance profiles and biocompatibility, creating opportunities for system suppliers to differentiate on consumable performance. New entrants, often backed by venture capital or strategic partnerships, are pushing user-centric designs, remote monitoring capabilities and simplified maintenance profiles to dislodge incumbents in home and ambulatory segments.

Strategically, partnerships between device OEMs, software firms and care providers are becoming more common to deliver integrated offerings that combine hardware with analytics and care coordination. Mergers, selective acquisitions and co-development agreements are being used to accelerate time-to-market for next-generation devices, while strategic investments in manufacturing flexibility enable faster responses to regional demand shifts. Ultimately, competitive advantage will increasingly hinge not only on device performance but on the ability to deliver validated clinical workflows, responsive service models and demonstrable contributions to patient-reported outcomes and overall care economics.

Actionable recommendations for industry leaders to strengthen resilience, accelerate digital transformation, optimize sourcing and scale home-focused device adoption effectively

Industry leaders must adopt pragmatic strategies that balance near-term resilience with long-term innovation to thrive in the evolving nephrology devices sector. First, prioritizing modular product architectures can accelerate regulatory filings across multiple variants and reduce time-to-adapt for localized configurations, enabling faster responses to tariff-driven sourcing changes. Second, investing in interoperable digital platforms that enable remote monitoring, predictive maintenance and integration with electronic health records will differentiate offerings and support value-based care discussions with payers and providers. Third, strategic supplier diversification and localized assembly capabilities should be pursued to mitigate import exposure while ensuring quality and regulatory compliance; these moves should be accompanied by rigorous change control and clinical validation plans.

Additionally, manufacturers should develop tailored commercial models for home care and non-traditional settings, including simplified training curricula, virtual onboarding, and bundled service contracts that address both clinical and logistical barriers to adoption. Collaborative pilot programs with large provider networks and payers can generate pragmatic evidence of clinical and economic value while accelerating adoption. Finally, companies should proactively engage with regulators and standards bodies to shape safe and pragmatic pathways for software-enabled devices and connected consumables, thereby reducing approval uncertainty and fostering wider market acceptance.

Transparent mixed-methods research approach detailing primary expert engagement, secondary evidence synthesis, validation protocols and analytical frameworks used for this report

The research underpinning this analysis employed a mixed-methods approach combining structured primary engagement with subject-matter experts and rigorous secondary evidence synthesis. Primary inputs included in-depth interviews with clinical leaders, procurement officers, device engineers and regulatory specialists to capture firsthand perspectives on adoption barriers, clinical prioritization and sourcing strategies. These insights were triangulated with secondary sources such as peer-reviewed clinical literature, publicly available regulatory documents, patent filings and company disclosures to validate technical claims and historical product trajectories. Cross-validation workshops with domain experts were used to reconcile divergent viewpoints and refine thematic conclusions.

Analytical frameworks integrated qualitative findings with supply chain mapping, regulatory pathway analysis and product segmentation to surface actionable insights. Where appropriate, sensitivity checks and scenario planning were applied to examine how policy shifts, such as tariff adjustments, might influence strategic responses. Quality assurance steps included methodological transparency, documentation of interview protocols, and review cycles with independent experts to ensure robustness. This layered methodology supports the credibility of the findings while providing clear traceability from raw inputs to strategic implications.

Final synthesis connecting clinical trends, technology enablement, policy headwinds and strategic imperatives that will shape the future trajectory of nephrology devices

In conclusion, the nephrology devices landscape is entering a phase defined by greater decentralization of care, intensified expectations for digital integration, and heightened sensitivity to supply chain and policy shocks. Clinical imperatives for safer, more patient-centric therapies are converging with technological enablers to create high-potential pathways for home and ambulatory solutions, while intensive care modalities continue to demand precision and reliability. Concurrently, tariff trajectories and regional regulatory diversity require nimble manufacturing and commercialization strategies that reconcile global scale with local adaptation.

Looking ahead, organizations that integrate modular product design, invest in digital ecosystems, and execute disciplined supply chain diversification will be better positioned to capture emerging opportunities. Strategic collaboration across the ecosystem-including manufacturers, software providers, providers and payers-will accelerate evidence generation and adoption. By focusing on demonstrable clinical benefits, streamlined user experiences, and resilient operations, stakeholders can navigate near-term headwinds while laying the groundwork for sustainable innovation in nephrology care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Nephrology Devices Market, by Product Type

  • 8.1. Accessories
    • 8.1.1. Blood Tubing Sets
    • 8.1.2. Dialysate Concentrates
    • 8.1.3. Filters And Membranes
  • 8.2. Catheters
    • 8.2.1. Peritoneal Dialysis Catheters
    • 8.2.2. Vascular Access Catheters
  • 8.3. Continuous Renal Replacement Therapy Devices
  • 8.4. Dialyzers
    • 8.4.1. High Flux Dialyzers
    • 8.4.2. Low Flux Dialyzers
    • 8.4.3. Ultra Low Flux Dialyzers
  • 8.5. Hemodialysis Machines
    • 8.5.1. Home Hemodialysis Machine
    • 8.5.2. Portable Hemodialysis Device
    • 8.5.3. Stationary Hemodialysis Machine
  • 8.6. Peritoneal Dialysis Systems

9. Nephrology Devices Market, by Modality

  • 9.1. Continuous Renal Replacement Therapy
    • 9.1.1. Continuous Venovenous Hemodiafiltration
    • 9.1.2. Continuous Venovenous Hemodialysis
    • 9.1.3. Continuous Venovenous Hemofiltration
  • 9.2. Hemodialysis
    • 9.2.1. Home Hemodialysis
    • 9.2.2. In Center Hemodialysis
  • 9.3. Peritoneal Dialysis
    • 9.3.1. Automated Peritoneal Dialysis
    • 9.3.2. Continuous Ambulatory Peritoneal Dialysis

10. Nephrology Devices Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Home Care Settings
  • 10.3. Hospitals
  • 10.4. Standalone Dialysis Centers

11. Nephrology Devices Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Nephrology Devices Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Nephrology Devices Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. United States Nephrology Devices Market

15. China Nephrology Devices Market

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025
  • 16.5. Allmed Medical Products Co., Ltd.
  • 16.6. Asahi Kasei Corporation
  • 16.7. B. Braun Melsungen AG
  • 16.8. Baxter International, Inc.
  • 16.9. Becton, Dickinson and Company
  • 16.10. DaVita Inc.
  • 16.11. Dialife SA
  • 16.12. Diaverum AB
  • 16.13. Fresenius Medical Care AG & Co. KGaA
  • 16.14. Guangdong Biolight Meditech Co., Ltd.
  • 16.15. Hemoclean Co., Ltd.
  • 16.16. Isopure Corporation
  • 16.17. JMS Co., Ltd.
  • 16.18. Kawasumi Laboratories, Inc.
  • 16.19. Lepu Medical Technology (Beijing) Co., Ltd.
  • 16.20. Medtronic plc
  • 16.21. Nikkiso Co., Ltd.
  • 16.22. Nipro Corporation
  • 16.23. Outset Medical, Inc.
  • 16.24. Quanta Dialysis Technologies Ltd.
  • 16.25. Rockwell Medical, Inc.
  • 16.26. STERIS plc
  • 16.27. Teleflex Incorporated
  • 16.28. Toray Industries, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NEPHROLOGY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL NEPHROLOGY DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. UNITED STATES NEPHROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 11. CHINA NEPHROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY ACCESSORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY BLOOD TUBING SETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY BLOOD TUBING SETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY BLOOD TUBING SETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY DIALYSATE CONCENTRATES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY DIALYSATE CONCENTRATES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY DIALYSATE CONCENTRATES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY FILTERS AND MEMBRANES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY FILTERS AND MEMBRANES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY FILTERS AND MEMBRANES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY VASCULAR ACCESS CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY VASCULAR ACCESS CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY VASCULAR ACCESS CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY DIALYZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY DIALYZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY DIALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HIGH FLUX DIALYZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HIGH FLUX DIALYZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HIGH FLUX DIALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY LOW FLUX DIALYZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY LOW FLUX DIALYZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY LOW FLUX DIALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY ULTRA LOW FLUX DIALYZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY ULTRA LOW FLUX DIALYZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY ULTRA LOW FLUX DIALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS MACHINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS MACHINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS MACHINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS MACHINES, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HOME HEMODIALYSIS MACHINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HOME HEMODIALYSIS MACHINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HOME HEMODIALYSIS MACHINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY PORTABLE HEMODIALYSIS DEVICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY PORTABLE HEMODIALYSIS DEVICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY PORTABLE HEMODIALYSIS DEVICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY STATIONARY HEMODIALYSIS MACHINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY STATIONARY HEMODIALYSIS MACHINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY STATIONARY HEMODIALYSIS MACHINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMODIAFILTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMODIAFILTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMODIAFILTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMODIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMODIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMODIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMOFILTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMOFILTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMOFILTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HOME HEMODIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HOME HEMODIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HOME HEMODIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY IN CENTER HEMODIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY IN CENTER HEMODIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY IN CENTER HEMODIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY AUTOMATED PERITONEAL DIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY AUTOMATED PERITONEAL DIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY AUTOMATED PERITONEAL DIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL DIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL DIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL DIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY STANDALONE DIALYSIS CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY STANDALONE DIALYSIS CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY STANDALONE DIALYSIS CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS NEPHROLOGY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS NEPHROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS NEPHROLOGY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS NEPHROLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS NEPHROLOGY DEVICES MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS MACHINES, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS NEPHROLOGY DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS NEPHROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS MACHINES, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS MACHINES, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY DEVICES MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS MACHINES, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE NEPHROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE NEPHROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE NEPHROLOGY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE NEPHROLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE NEPHROLOGY DEVICES MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS MACHINES, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE NEPHROLOGY DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE NEPHROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST NEPHROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST NEPHROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST NEPHROLOGY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST NEPHROLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST NEPHROLOGY DEVICES MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS MACHINES, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST NEPHROLOGY DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST NEPHROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA NEPHROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA NEPHROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA NEPHROLOGY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA NEPHROLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA NEPHROLOGY DEVICES MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS MACHINES, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA NEPHROLOGY DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA NEPHROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC NEPHROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC NEPHROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC NEPHROLOGY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC NEPHROLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC NEPHROLOGY DEVICES MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS MACHINES, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC NEPHROLOGY DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC NEPHROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN NEPHROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN NEPHROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN NEPHROLOGY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN NEPHROLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN NEPHROLOGY DEVICES MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS MACHINES, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN NEPHROLOGY DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN NEPHROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 206. GCC NEPHROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 207. GCC NEPHROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. GCC NEPHROLOGY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 209. GCC NEPHROLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 210. GCC NEPHROLOGY DEVICES MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 211. GCC NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS MACHINES, 2018-2032 (USD MILLION)
  • TABLE 212. GCC NEPHROLOGY DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 213. GCC NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
  • TABLE 214. GCC NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 215. GCC NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 216. GCC NEPHROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION NEPHROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION NEPHROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION NEPHROLOGY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION NEPHROLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION NEPHROLOGY DEVICES MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS MACHINES, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION NEPHROLOGY DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION NEPHROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS NEPHROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS NEPHROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS NEPHROLOGY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS NEPHROLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS NEPHROLOGY DEVICES MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS MACHINES, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS NEPHROLOGY DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS NEPHROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 239. G7 NEPHROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 240. G7 NEPHROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. G7 NEPHROLOGY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 242. G7 NEPHROLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 243. G7 NEPHROLOGY DEVICES MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 244. G7 NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS MACHINES, 2018-2032 (USD MILLION)
  • TABLE 245. G7 NEPHROLOGY DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 246. G7 NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
  • TABLE 247. G7 NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 248. G7 NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 249. G7 NEPHROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 250. NATO NEPHROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 251. NATO NEPHROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 252. NATO NEPHROLOGY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 253. NATO NEPHROLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 254. NATO NEPHROLOGY DEVICES MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 255. NATO NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS MACHINES, 2018-2032 (USD MILLION)
  • TABLE 256. NATO NEPHROLOGY DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 257. NATO NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
  • TABLE 258. NATO NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 259. NATO NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 260. NATO NEPHROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 261. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES NEPHROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES NEPHROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED STATES NEPHROLOGY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES NEPHROLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES NEPHROLOGY DEVICES MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED STATES NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS MACHINES, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES NEPHROLOGY DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED STATES NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED STATES NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED STATES NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED STATES NEPHROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 273. CHINA NEPHROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 274. CHINA NEPHROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 275. CHINA NEPHROLOGY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 276. CHINA NEPHROLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 277. CHINA NEPHROLOGY DEVICES MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 278. CHINA NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS MACHINES, 2018-2032 (USD MILLION)
  • TABLE 279. CHINA NEPHROLOGY DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 280. CHINA NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
  • TABLE 281. CHINA NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 282. CHINA NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 283. CHINA NEPHROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)